Prestige Consumer Healthcare (PBH) Net Margin Growth (1y) (2011 - 2025)
Prestige Consumer Healthcare (PBH) Net Margin Growth (1y) (2011 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.15 Bn | 39.49 Bn | 2.15 Bn | -2,064.00 |
| 3 | Zoetis | 31.52 Bn | 29.84 Bn | 1.05 Bn | -177.00 |
| 4 | Takeda Pharmaceutical | 28.58 Bn | 22.78 Bn | 5.10 Bn | -195.00 |
| 5 | United Therapeutics | 22.16 Bn | 19.50 Bn | 683.80 Mn | 376.00 |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn | -303.00 |
| 7 | Neurocrine Biosciences | 15.48 Bn | 15.09 Bn | 935.80 Mn | -58.00 |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn | 306.00 |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - | - |
| 10 | Prestige Consumer Healthcare | 2.44 Bn | 2.37 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -455.00 |
| Sep 30, 2025 | -376.00 |
| Jun 30, 2025 | 65.00 |
| Mar 31, 2025 | -95.00 |
| Dec 31, 2024 | 226.00 |
| Sep 30, 2024 | 46.00 |
| Jun 30, 2024 | -71.00 |
| Mar 31, 2024 | 10,200.00 |
| Dec 31, 2023 | -9.00 |
| Sep 30, 2023 | 107.00 |
| Jun 30, 2023 | -88.00 |
| Mar 31, 2023 | -10,366.00 |
| Dec 31, 2022 | 56.00 |
| Sep 30, 2022 | 123.00 |
| Jun 30, 2022 | -151.00 |
| Mar 31, 2022 | 458.00 |
| Dec 31, 2021 | 118.00 |
| Sep 30, 2021 | -237.00 |
| Jun 30, 2021 | 240.00 |
| Mar 31, 2021 | 19.00 |